Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells (Clinical Epigenetics, (2019), 11, 1, (68), 10.1186/s13148-019-0663-8)

Clemens Zwergel, Michael Schnekenburger, Federica Sarno, Cecilia Battistelli, Maria Cristina Manara, Giulia Stazi, Roberta Mazzone, Rossella Fioravanti, Christina Gros, Frédéric Ausseil, Cristina Florean, Angela Nebbioso, Raffaele Strippoli, Toshikazu Ushijima, Katia Scotlandi, Marco Tripodi, Paola B. Arimondo, Lucia Altucci, Marc Diederich, Antonello Mai*Sergio Valente*

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Abstract

Figure 6 of the original publication [1] contained a picture duplication in the U-937 panel resulting from an error while copy/pasting the individual pictures used to prepare the figure. The erroneous picture panel did not affect the corresponding quantification of cell death and the interpretation of the results as it was done with the correct picture set. The corrected Fig. 6 is presented in this correction.

Original languageEnglish
Article number119
JournalClinical Epigenetics
Volume14
Issue number1
DOIs
Publication statusPublished - Dec 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells (Clinical Epigenetics, (2019), 11, 1, (68), 10.1186/s13148-019-0663-8)'. Together they form a unique fingerprint.

Cite this